TrialEuropean journal of heart failure2018

Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.

Christian Delles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.